Midgard Science

Biomay AG

Vienna, Austria biomay.com

From their website, Nov 2026

Work here? Claim this listing

About

Biomay AG is a biopharmaceutical CDMO in Vienna, Austria. It manufactures GMP-grade plasmid DNA, mRNA, recombinant proteins, and related drug products for clinical phases I–III and market supply. The company operates two GMP manufacturing sites in Vienna.

Services

  • Vector development

    Develops vectors for plasmids, proteins, and mRNA.

    Cell line development

  • GMP cell banking

    Creates Master Cell Banks and Working Cell Banks.

    Cell line development

  • Process development and feasibility studies

    Carries out process development and feasibility work for client projects.

  • Analytical development / quality control methods

    Develops analytical methods and quality control methods for project support.

  • GMP manufacturing of bulk drug substance

    Manufactures bulk drug substance for clinical phases I–III and market supply.

    CDMO: development & manufacturing

  • GMP aseptic filling of drug product

    Performs aseptic filling of drug product for clinical phases I–III.

    CDMO: development & manufacturing

  • Quality control and Qualified Person release

    Provides quality control and QP release services.

  • Analytical method and process validation (PPQ)

    Supports analytical method validation and process validation activities.

  • Regulatory support

    Provides regulatory support for client programs.

  • ICH stability testing & long-term storage

    Conducts ICH stability testing and long-term storage.

  • Aseptic filling

    Offers cGMP fill & finish services for DNA, proteins, and RNA.

    CDMO: development & manufacturing

  • Personalized manufacturing

    Manufactures patient-specific DNA and mRNA cancer vaccines within a few weeks.

    CDMO: development & manufacturing

Turnaround
Within a couple of weeks · From incoming of starting material to released mRNA-LNP in three weeks · From incoming of starting material to released plasmid DNA in two weeks · Personalized DNA cancer vaccines in as little as two weeks · mRNA-based vaccines in approximately three weeks
What to send
In-silico sequence of individual patient mRNA provided by sponsor · DNA fragment synthesis as starting material (external) · In-silico sequence of individual patient DNA provided by sponsor

Capabilities

Assays and studies
mRNA · Fill-finish · LNP · Analytical development · Cell-free expression · Process development · Quality control · Qualified person release · Analytical method validation · Process validation · ICH stability testing · In-house rapid sterility testing
1 moreAssay development
Scale and capacity
Two GMP manufacturing sites · 10 segregated GMP clean room suites · Total floor space 6000 sqm / 60,000 sq ft · Headquarter facility 4000 sqm total floor space · mRNA Competence Center 2000 sqm total floor space · Bioreactor capacities: 30L, 50L, 150L, 750L · Personalized bioreactor capacities: 4 x 3L · Capacity up to 1500 2R glass vials per batch · Up to 1500 sterile-filled vials per batch · Up to 50 mg mRNA per patient · Up to 300 mg DNA per patient
Therapeutic areas
Cancer immunotherapy · Gene editing · ATMPs

Instruments and platforms

  • Automated filling / stoppering line
  • High-pressure homogenizers
  • Centrifuges
  • Process chromatography equipment

Modalities and species

Modalities
mRNA · Viral vector · Gene editing · Recombinant protein · Vaccine · Plasmid DNA · LNP / formulation
Species and models
E. coli

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: plasmid DNA, mRNA, recombinant proteins, aseptic filling, personalized batches

Company

Type
CDMO
Founded
1984

Locations

Address
Ada-Lovelace-Straße 2; 1220 Vienna, Austria
Sites
Vienna, Austria · Vienna 1220 (Aspern Seestadt), Austria · Vienna 1090, Austria
Serves
North America

Public records

Parent company
BIOMAY AG · AT GLEIF

Similar labs

Work here? Claim this listing